Cloud Banner

Product Launch (Blog)

Mar, 04 2022

Global API Intermediates Market is Growing with CAGR of 6.4% in the Forecast Period of 2021 to 2028

The API intermediates industry will relinquish an approximated estimate at a frequency of 6.4% for the projection space of 2021 to 2028 with factor such as high burden of chronic diseases and increasing geriatric population. Increasing disease awareness and education also acts as a major factor for the growth of the API intermediates market. Utilization of advanced technology in active pharmaceutical ingredients (API) manufacturing and research and development regarding pharmaceutical APIs and their intermediates have also given a boom to the global API intermediates market.

The soaring number of API intermediates manufacturers has propelled the demand of the API intermediates market. However, availability of sub-standard and counterfeit drugs and product recalls has decreased the demand of the API intermediates market.

Global API Intermediates Market Scenario                               

According to Data Bridge Market Research, the market for API intermediates in North America region has the highest market share followed by Europe and Asia-Pacific. Market leader is Aurobindo Pharma which accounts larger market share globally. The company has gained outstanding sale by providing novel API intermediates.

  • In January 2021, Aurobindo Pharma has received the financial support from the central government under the production linked incentive (PLI) scheme. The government has announced to offer the PLI for the bulk drugs and intermediates in order to reduce the import dependency of the products in the country. This approval and support from the government accelerated the company’s drug manufacturing abilities.

API Intermediates Market

Trends Impacting the API Intermediates Market

Now the question is which other regions Aurobindo Pharma, Divi's Laboratories Limited and BASF SE are targeting? Data Bridge Market Research has forecasted a large growth in North America API intermediates market and the market leaders targeting the U.S. and Canada to be their next revenue pocket for 2021.

The global API intermediates market is becoming more competitive with companies such as Aurobindo Pharma, Divi's Laboratories Limited and BASF SE as they are the market leaders for API intermediates. These are the top dominating companies in API intermediates market and are launching more new API intermediates in the market. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global API intermediates market.

For more analysis on the global API intermediates market, request for a briefing with our analysts

New API Intermediates Market Development

  • In February 2021, Cambrex Corporation had received the CMO Leadership Awards and had received an award for six different categories such as capabilities, compatibility, expertise, quality, reliability and services. The company has strengthened their position as one of the leading CDMO that is contract development and manufacturing organization. This recognition helped the company to boost up their manufacturing skills.

Scope of the Global API Intermediates Market

Global API intermediates market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and rest of Middle East and Africa.

  • All country based analysis of the global API intermediates market is further analyzed based on maximum granularity into further segmentation. On the basis of type, the API intermediates market is segmented into veterinary drug intermediates and pharmaceutical / bulk drug intermediates. On the basis of product, the API intermediates market is segmented into bromo compound, O-benzyl salbutamol, hemisulfate, oxirane, bisoprolol base, chiral PCBHP, pheniramine base, chlorpheniramine base, brompheniramine base, mepyramine/pyrilamine base, 6-amino-1,3-dimethyl uracil, theofylline, acefylline, xanthine, nitriles and others. On the basis of therapeutic type, the API intermediates market is segmented into autoimmune diseases, oncology, metabolic diseases, ophthalmology, cardiovascular diseases, infectious diseases, neurology, respiratory disorders, dermatology, urology and others. On the basis of customers, the API intermediates market is segmented into direct users/pharma companies, traders/wholesalers/distributors and associations/govt. institutions/Pvt institutions. On the basis of end user, the API intermediates market is segmented into API manufacturer and finished product manufacturer. On the basis of distribution channel, the API intermediates market is segmented into direct tender, retail sales and others.

To know more about the study

Key Pointers Covered in Global API Intermediates Market Industry Trends and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Market Value and Over View of API Intermediates
  • Company Profiling of Top Eight Players of API Intermediates Market

Key Market Competitors Covered in the Report

  • HIKAL Ltd.
  • Cambrex Corporation
  • Ganesh-Group
  • AlzChem Group AG
  • Vasudha Pharma
  • Anyang General Chemical Co.,Ltd.
  • Sarex
  • Sandoo Pharmaceuticals and Chemicals Co., Ltd.
  • Atul Ltd
  • Sandoz International GmbH (a subsidiary of Novartis AG)
  • Aceto
  • Supriya Lifescience Ltd.
  • Vertellus
  • Dishman Carbogen Amcis Ltd
  • Sanofi
  • Divi's Laboratories Limited
  • Aurobindo Pharma

Above are the key players covered in the report, to know about more and exhaustive list of API intermediates companies’, contact us

Research Methodology: Global API Intermediates Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Manufacturers, Healthcare Industries, Scientists and Research Laboratories.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@

Client Testimonials